FDA panel backs XFG strain for 2026-27 COVID vaccine update
Source: SeekingAlpha
2026-05-29 05:00:10 ET
More on Moderna, Pfizer, etc.
- Pfizer: Reduced TrumpRx/Patent Risks Meet Accretive M&A Efforts - Reiterate Buy
- FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer
- Moderna, Inc. (MRNA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
- Pfizer signs up to $10.5B oncology deal with China’s Innovent
- FDA AdCom panel to review and vote on next COVID shots
Read the full article on Seeking Alpha
For further details see:
FDA panel backs XFG strain for 2026-27 COVID vaccine update
BioNTech SE
NASDAQ: BNTX
BNTX Trading
-1.68% G/L:
$88.41 Last:
272,886 Volume:
$89.51 Open:
BNTX Latest News
June 03, 2026 09:15:58 am
The Multi-Billion-Dollar Race to Defeat Glioblastoma: Why Investors Are Watching One of Oncology's Most Challenging Frontiers
BNTX Stock Data
$26,377,590,776
95,508,380
N/A
104
N/A
Biotechnology & Life Sciences
Healthcare
DE
Mainz
